Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis.

Department of Neuroscience and Biomedical Technologies, University of Milan Bicocca, and Department of Neurology, S. Gerardo Hospital, Monza, Italy.
Journal of Neuroimmunology (Impact Factor: 2.79). 07/2004; 151(1-2):55-65. DOI: 10.1016/j.jneuroim.2004.02.008
Source: PubMed

ABSTRACT Pixantrone is less cardiotoxic and is similarly effective to mitoxantrone (MTX) as an antineoplastic drug. In our study, pixantrone reduced the severity of acute and decreased the relapse rate of chronic relapsing experimental allergic encephalomyelitis (EAE) in rats. A marked and long-lasting decrease in CD3+, CD4+, CD8+ and CD45RA+ blood cells and reduced anti-MBP titers were observed with both pixantrone and MTX. In vitro mitogen- and antigen-induced T-cell proliferation tests of human and rodents cells evidenced that pixantrone was effective at concentrations which can be effectively obtained after i.v. administration in humans. Cardiotoxicity was present only in MTX-treated rats. The effectiveness and the favorable safety profile makes pixantrone a most promising immunosuppressant agent for clinical use in multiple sclerosis (MS).

  • [Show abstract] [Hide abstract]
    ABSTRACT: Microtubules undergo continual dynamic changes in mitotic cells as the mitotic spindle forms and is broken down and in interphase cells where they play a central role in intracellular trafficking, cell signaling, cell migration, and angiogenesis. Compounds that target the microtubule have been hugely successful in the clinic as chemotherapeutics, and this success is likely due to their ability to target cells regardless of their cell cycle stage. Additionally, new generation antibody-conjugated microtubule-targeting agents are improving the targeting of these drugs to tumors. Microtubule-targeting agents have been shown to have anti-angiogenic and vascular-disrupting properties as well as effects on cellular migration, intracellular trafficking, and cell secretion. There are a number of these compounds in development that target the vasculature, and different formulations of clinically used drugs are being developed to take advantage of these anti-angiogenic properties. Microtubule-targeting agents have also been shown to have the potential to treat neurodegenerative diseases, such as Alzheimer's disease. Thus, drugs that target the microtubule will continue to have a major impact in oncology not only as anti-mitotics but also as potent inhibitors of interphase functions, and in future may also prove to be effective in reducing the consequences of neurodegenerative disease.
    Bioorganic & medicinal chemistry 03/2014; DOI:10.1016/j.bmc.2014.02.035 · 2.95 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A Sagnac interferometer with a long-period fiber grating (LPG) inscribed in the polarization-maintaining fiber (PMF) is proposed and experimentally demonstrated for simultaneous measurement of strain and temperature. Due to the different responses of the LPG and the Sagnac interferometer to strain and temperature, simultaneous measurement can be achieved by monitoring the wavelength shifts and the intensity changes of a resonance dip of the sensor setup. The experimental results show that the achieved sensitivities to strain and temperature are 6.4×10−3dB/με and 0.65nm/°C, respectively.
    Optics Communications 04/2011; 284(8):2145-2148. DOI:10.1016/j.optcom.2011.01.002 · 1.54 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A new and efficient strategy for the synthesis of 3-substituted 1-hydroxybenz[g]isoquinoline-5,10-diones by reaction of 2-methoxycarbonyl-1,4-naphthoquinone with different pyridinium salts under Kröhnke conditions is disclosed. This one-step reaction was found to be dependent on the substitution pattern of the aromatic nucleus in the pyridinium salts.
    ChemInform 02/2009; 65(6):1193–1199. DOI:10.1016/j.tet.2008.11.070